Identification of DTL as Related Biomarker and Immune Infiltration Characteristics of Nasopharyngeal Carcinoma via Comprehensive Strategies

References

• Chen YP, Chan AT, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi:10.1016/S0140-6736(19)30956-0
   PubMed Web of Science ®Google Scholar
• Peng L, Liu JQ, Xu C, et al. The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma. Radiat Oncol. 2019;14(1):9. doi:10.1186/s13014-019-1213-4
   PubMed Web of Science ®Google Scholar
• Mao YP, Xie FY, Liu LZ, et al. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2009;73(5):1326–1334. doi:10.1016/j.ijrobp.2008.07.062
   PubMed Web of Science ®Google Scholar
• Chan KC, Hung EC, Woo JK, et al. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program. Cancer. 2013;119(10):1838–1844. doi:10.1002/cncr.28001
   PubMed Web of Science ®Google Scholar
• King AD, Woo JK, Ai QY, et al. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma. Ann Oncol. 2019;30(6):977–982. doi:10.1093/annonc/mdz106
   PubMed Web of Science ®Google Scholar
• Liu ZW, Ji MF, Huang QH, et al. Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China. Am J Epidemiol. 2013;177(3):242–250. doi:10.1093/aje/kws404
   PubMed Web of Science ®Google Scholar
• Coghill AE, Hsu W-L, Pfeiffer RM, et al. Epstein–Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1213–1219. doi:10.1158/1055-9965.EPI-13-1262
   PubMed Web of Science ®Google Scholar
• Lee AW, Ng WT, Chan L, et al. Evolution of treatment for nasopharyngeal cancer–success and setback in the intensity-modulated radiotherapy era. Radiother Oncol. 2014;110(3):377–384. doi:10.1016/j.radonc.2014.02.003
   PubMed Web of Science ®Google Scholar
• Luo WR, Chen XY, Li SY, et al. Neoplastic spindle cells in nasopharyngeal carcinoma show features of epithelial-mesenchymal transition. Histopathology. 2012;61(1):113–122. doi:10.1111/j.1365-2559.2012.04205.x
   PubMed Web of Science ®Google Scholar
• Luo WR, Yao KT. Molecular characterization and clinical implications of spindle cells in nasopharyngeal carcinoma: a novel molecule-morphology model of tumor progression proposed. PLoS One. 2013;8(12):e83135. doi:10.1371/journal.pone.0083135
   PubMed Web of Science ®Google Scholar
• Han BA, Yang XP, Zhang P, et al. DNA methylation biomarkers for nasopharyngeal carcinoma. PLoS One. 2020;15(4):e0230524. doi:10.1371/journal.pone.0230524
   PubMed Web of Science ®Google Scholar
• Baştanlar Y, Ozuysal M. Introduction to machine learning. Methods Mol Biol. 2014;1107:105–128.
   PubMedGoogle Scholar
• Barbounaki S, Vivilaki VG. Intelligent systems in obstetrics and midwifery: applications of machine learning. Eur J Midwifery. 2021;5:58. doi:10.18332/ejm/143166
   PubMedGoogle Scholar
• Dai CX, Sun BW, Wang RZ, et al. The application of artificial intelligence and machine learning in pituitary adenomas. Front Oncol. 2021;11:784819. doi:10.3389/fonc.2021.784819
   PubMed Web of Science ®Google Scholar
• Kolluri S, Lin JC, Liu R, et al. Machine learning and artificial intelligence in pharmaceutical research and development: a review. AAPS J. 2022;24(1):19. doi:10.1208/s12248-021-00644-3
   PubMed Web of Science ®Google Scholar
• Dodd LE, Sengupta S, Chen IH, et al. Genes involved in DNA repair and nitrosamine metabolism and those located on chromosome 14q32 are dysregulated in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2216–2225. doi:10.1158/1055-9965.EPI-06-0455
   PubMed Web of Science ®Google Scholar
• Sengupta S, den Boon JA, Chen IH, et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res. 2006;66(16):7999–8006. doi:10.1158/0008-5472.CAN-05-4399
   PubMed Web of Science ®Google Scholar
• Hsu WL, Tse KP, Liang S, et al. Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma. PLoS One. 2012;7(8):e42767. doi:10.1371/journal.pone.0042767
   PubMed Web of Science ®Google Scholar
• Bose S, Yap LF, Fung M, et al. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J Pathol. 2009;217(3):345–352. doi:10.1002/path.2487
   PubMed Web of Science ®Google Scholar
• Fan C, Wang J, Tang Y, et al. Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers. BMC Cancer. 2020;20(1):917.
   PubMed Web of Science ®Google Scholar
• Bo H, Gong Z, Zhang W, et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget. 2015;6(24):20404–20418. doi:10.18632/oncotarget.4057
   PubMedGoogle Scholar
• Bao YN, Cao X, Luo DH, et al. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis. Cell Cycle. 2014;13(12):1958–1969. doi:10.4161/cc.28921
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Alhamzawi R, Ali HTM. The Bayesian adaptive lasso regression. Math Biosci. 2018;303:75–82. doi:10.1016/j.mbs.2018.06.004
   PubMed Web of Science ®Google Scholar
• Alakwaa FM, Chaudhary K, Garmire LX. Deep learning accurately predicts estrogen receptor status in breast cancer metabolomics data. J Proteome Res. 2018;17(1):337–347. doi:10.1021/acs.jproteome.7b00595
   PubMed Web of Science ®Google Scholar
• Lin X, Yang F, Zhou L, et al. A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;910:149–155. doi:10.1016/j.jchromb.2012.05.020
   PubMed Web of Science ®Google Scholar
• Liao R, Ma QZ, Zhou CY, et al. Identification of biomarkers related to Tumor-Infiltrating Lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer. Bioengineered. 2021;12(1):1676–1688. doi:10.1080/21655979.2021.1921551
   PubMed Web of Science ®Google Scholar
• Huang ML, Hung YH, Lee WM, et al. SVM-RFE based feature selection and Taguchi parameters optimization for multiclass SVM classifier. Sci World J. 2014;2014:795624. doi:10.1155/2014/795624
   Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12(1):77. doi:10.1186/1471-2105-12-77
   PubMed Web of Science ®Google Scholar
• Xue G, Hua L, Zhou N, et al. Characteristics of immune cell infiltration and associated diagnostic biomarkers in ulcerative colitis: results from bioinformatics analysis. Bioengineered. 2021;12(1):252–265. doi:10.1080/21655979.2020.1863016
   PubMed Web of Science ®Google Scholar
• Serang S, Jacobucci R, Brimhall KC, et al. Exploratory mediation analysis via regularization. Struct Equ Modeling. 2017;24(5):733–744. doi:10.1080/10705511.2017.1311775
   PubMed Web of Science ®Google Scholar
• Xu C, Yu L, Zhan P, et al. Elevated pleural effusion il-17 is a diagnostic marker and outcome predictor in lung cancer patients. Eur J Med Res. 2014;19(1):23. doi:10.1186/2047-783X-19-23
   PubMed Web of Science ®Google Scholar
• Song Y, Yang JM. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer. Biochem Biophys Res Commun. 2017;493(1):1–8. doi:10.1016/j.bbrc.2017.08.109
   PubMed Web of Science ®Google Scholar
• Li J, Mo HY, Xiong G, et al. Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients. J Biol Chem. 2012;287(42):35484–35495. doi:10.1074/jbc.M112.367532
   PubMed Web of Science ®Google Scholar
• Wang LX, Ma RX, Di LL, et al. Correlation between IL-17A expression in nasopharyngeal carcinoma tissues and cells and pathogenesis of NPC in endemic areas. Eur Arch Otorhinolaryngol. 2019;276(11):3131–3138. doi:10.1007/s00405-019-05608-0
   PubMed Web of Science ®Google Scholar
• Roy LD, Sahraei M, Schettini JL, et al. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches. BMC Cancer. 2014;14:225. doi:10.1186/1471-2407-14-225
   PubMed Web of Science ®Google Scholar
• Cai K, Wang B, Dou H, et al. IL-17A promotes the proliferation of human nasopharyngeal carcinoma cells through p300-mediated Akt1 acetylation. Oncol Lett. 2017;13(6):4238–4244.
   PubMed Web of Science ®Google Scholar
• Sanz H, Valim C, Vegas E, et al. SVM-RFE: selection and visualization of the most relevant features through non-linear kernels. BMC Bioinform. 2018;19(1):432. doi:10.1186/s12859-018-2451-4
   PubMed Web of Science ®Google Scholar
• Pan HW, Chou HY, Liu SH, et al. Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma. Cell Cycle. 2006;5(22):2676–2687. doi:10.4161/cc.5.22.3500
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Komatsu S, Ichikawa D, et al. Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma. Oncotarget. 2015;6(34):36615–36624. doi:10.18632/oncotarget.5620
   PubMedGoogle Scholar
• Abbas T, Dutta A. CRL4Cdt2: master coordinator of cell cycle progression and genome stability. Cell Cycle. 2011;10(2):241–249. doi:10.4161/cc.10.2.14530
   PubMed Web of Science ®Google Scholar
• Mackintosh C, Ordóñez JL, García DJ, et al. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene. 2012;31(10):1287–1298. doi:10.1038/onc.2011.317
   PubMed Web of Science ®Google Scholar
• Pan WW, Zhou JJ, Yu C, et al. Ubiquitin E3 ligase CRL4(CDT2/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer. J Biol Chem. 2013;288:29680–29691
   PubMed Web of Science ®Google Scholar
• Benamar M, Guessous F, Du KP, et al. Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma. EBioMedicine. 2016;10:85–100. doi:10.1016/j.ebiom.2016.06.023
   PubMed Web of Science ®Google Scholar
• Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009;136(5):823–837. doi:10.1016/j.cell.2009.02.024
   PubMed Web of Science ®Google Scholar
• Olivero M, Dettori D, Arena S, et al. The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase. Oncotarget. 2014;5(15):5992–6002. doi:10.18632/oncotarget.2042
   PubMedGoogle Scholar
• Yang L, Dai J, Ma M, et al. Identification of a functional polymorphism within the 3’-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma. Eur J Cancer. 2019;118:70–81. doi:10.1016/j.ejca.2019.06.006
   PubMed Web of Science ®Google Scholar
• Luo MS, Huang GJ, Liu BX. Immune infiltration in nasopharyngeal carcinoma based on gene expression. Medicine. 2019;98(39):e17311. doi:10.1097/MD.0000000000017311
   PubMed Web of Science ®Google Scholar
• Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218. doi:10.1186/s13059-016-1070-5
   PubMed Web of Science ®Google Scholar
• Jin SZ, Li RY, Chen MY, et al. Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell Res. 2020;30(11):950–965. doi:10.1038/s41422-020-00402-8
   PubMed Web of Science ®Google Scholar
• Wang YQ, Liu X, Xu C, et al. Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients. Oncoimmunology. 2021;10(1):1976439. doi:10.1080/2162402X.2021.1976439
   PubMed Web of Science ®Google Scholar
• Zhao S, Dong X, Ni XG, et al. Exploration of a novel prognostic risk signature and its effect on the immune response in nasopharyngeal carcinoma. Front Oncol. 2021;11:709931. doi:10.3389/fonc.2021.709931
   PubMed Web of Science ®Google Scholar
• Chen YP, Lv JW, Mao YP, et al. Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses. Mol Cancer. 2021;20(1):14. doi:10.1186/s12943-020-01292-5
   PubMed Web of Science ®Google Scholar
• Bruce JP, To KF, Lui WY, et al. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF- κB activation and immune escape. Nat Commun. 2021;12(1):4193. doi:10.1038/s41467-021-24348-6
   PubMed Web of Science ®Google Scholar